Use access key #2 to skip to page content.
$13.45 -0.29 (-2.11%)
9/5/2008 4:02 PM

Emergent BioSolutions, Inc. (EBS)

CAPS Rating:
*****

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

View All Commentary (EBS)

Recs

0

Avatar famman4 (< 20) Submitted: 7/12/08 8:04 AM : Outperform Start Price: $12.23 EBS Score: 10.75

As with many other references to the medical field and the baby boomers getting older and EBS is in a field where what they offer applies. Also, numbers are good.

Report this Post Replies: 0 | Reply

Featured Broker Partners